(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-(2H3)methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide

• ChemBase编号: 162676
• 分子式: C32H40BrN5O5
• 平均质量: 654.5945
• 单一同位素质量: 653.22128141
• SMILES: c1cc2[nH]c(c3C[C@@H]4C(=C[C@H](CN4C)C(=O)N[C@]4(C(=O)N5[C@@](O4)([C@H]4N(C(=O)[C@@H]5CC(C)C)CCC4)O)C(C)C)c(c1)c23)Br
• Canonical SMILES: CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
• InChI: InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1
• InChIKey: OZVBMTJYIDMWIL-AYFBDAFISA-N

名称和登记号

名称

• IUPAC标准名: (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^2,^6]dodecan-4-yl]-6-(^2H₃)methyl-6,11-diazatetracyclo[7.6.1.0^2,^7.0^1^2,^1^6]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
• IUPAC传统名: (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-4-isopropyl-7-(2-methylpropyl)-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^2,^6]dodecan-4-yl]-6-(^2H₃)methyl-6,11-diazatetracyclo[7.6.1.0^2,^7.0^1^2,^1^6]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
• 别名: (5’α)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione-d3; 2-Bromoergocryptine-d3; Bagren-d3; Bromocriptine-d3; Bromocryptine-d3; 2-Bromo-α-Ergocryptine-d3

登记号

• PubChem SID: 162256811
• PubChem CID: 71314182

理论计算性质

• Acid pKa: 9.677615
• 质子受体: 6
• 质子供体: 3
• LogD (pH = 5.5): 2.6492515
• LogD (pH = 7.4): 3.8034801
• Log P: 3.8871677
• 摩尔折射率: 165.5124 cm^3
• 极化性: 65.10812 Å^3
• 极化表面积: 118.21 Å^2
• 可自由旋转的化学键: 5
• 里宾斯基五规则: false

详细说明

Toronto Research Chemicals - B682602

Labelled 2-Bromo-α-Ergocryptine is a dopamine receptor agonist. 2-Bromo-α-Ergocryptine is a derivative of the ergotoxin group of ergot alkaloids. 2-Bromo-α-Ergocryptine is a prolactin inhibitor; antiparkinsonian.

参考文献

• Giron-Forest, D.A. et al.: Anal. Profiles Drug Subs., 8, 47 (1979)
• Camerman, N. et al.: Mol. Pharmacol., 19, 517 (1979)
• Ho, K.Y. et al.: Drugs, 36, 67 (1979)